OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii

被引:88
作者
Evans, B. A. [1 ]
Hamouda, A. [1 ]
Towner, K. J. [2 ]
Amyes, S. G. B. [1 ]
机构
[1] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH16 4SB, Midlothian, Scotland
[2] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Clin Microbiol, Nottingham, England
基金
英国医学研究理事会;
关键词
Acinetobacter baumannii; bla(OXA-51-like); carbapenemase; lineages; linkage map; sequence groups;
D O I
10.1111/j.1469-0691.2007.01919.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sixty diverse clinical Acinetobacter baumannii isolates of worldwide origin were assigned to sequence groups, based on a multiplex PCR for the ompA, csuE and bla(OXA-51-like) genes. The majority (77%) of isolates belonged to sequence groups 1 and 2 (SG1 and SG2), with sequence group 3 (SG3) and non-grouped isolates accounting for the remainder. The isolates were not closely related according to pulsed-field gel electrophoresis (PFGE), and the majority were sensitive to imipenem and meropenem. The construction of a linkage map of OXA-51-like beta-lactamase sequence relationships revealed two closely related clusters of enzymes, one focused around OXA-66 and the other around OXA-69. Isolates belonging to SG1 encoded an enzyme from the OXA-66 cluster, while those belonging to SG2 encoded an enzyme from the OXA-69 cluster. All SG3 isolates encoded OXA-71, which does not form part of a close enzyme grouping. Major multinational lineages accounted for a significant proportion of A. baumannii clinical isolates, and the evolution of the OXA-51-like enzymes appears to be an ongoing process.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 26 条
  • [1] BSAC standardized disc susceptibility testing method (version 6)
    Andrews, J. M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 20 - 41
  • [2] [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1
  • [3] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
    BergogneBerezin, E
    Towner, KJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
  • [4] The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents
    Brown, S
    Amyes, SGB
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) : 326 - 329
  • [5] Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina
    Brown, S
    Young, HK
    Amyes, SGB
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) : 15 - 23
  • [6] OXA β-lactamases in Acinetobacter:: the story so far
    Brown, S
    Amyes, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) : 1 - 3
  • [7] Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II
    Da Silva, G.
    Dijkshoorn, L.
    van der Reijden, T.
    van Strijen, B.
    Duarte, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (02) : 190 - 195
  • [8] Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods
    Dijkshoorn, L
    Aucken, H
    GernerSmidt, P
    Janssen, P
    Kaufmann, ME
    Garaizar, J
    Ursing, J
    Pitt, TL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) : 1519 - 1525
  • [9] Acinetobacter species identification by using tRNA spacer fingerprinting
    Ehrenstein, B
    Bernards, AT
    Dijkshoorn, L
    GernerSmidt, P
    Towner, KJ
    Bouvet, PJM
    Daschner, FD
    Grundmann, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2414 - 2420
  • [10] Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii
    Evans, B. A.
    Brown, S.
    Hamouda, A.
    Findlay, J.
    Amyes, S. G. B.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) : 1137 - 1138